Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

USA - English

News provided by

Mar 30, 2023, 10:52 ET

VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma^® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More

Contact:
Uschi Mayer
External Communications & PR
CROMA-PHARMA GmbH
Cromazeile 2, A-2100 Leobendorf, Austria
M.: +43 676 84 68 68 966
E: [email protected]

Logo: https://mma.prnewswire.com/media/2044449/Croma_Pharma_Logo.jpg